A pharmacophore model for sulphonyl-urea (-cyanoguanidine) compounds with dual action, thromboxane receptor antagonists and thromboxane synthase inhibitors

By Michaux C.   Dogne J.-M.   Rolin S.   Masereel B.   Wouters J.   Durant F.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 7, 2003-07 ,pp. : 703-710

Elsevier

Access to resources Recommend Favorite

Quantitative Structure Activity Relationships (QSARs) on Lipoxygenase Inhibitors

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 3, Iss. 2, 2004-06 ,pp. : 139-156

Bentham Science Publishers

Access to resources Recommend Favorite

Cysteinyl Leukotriene Receptor Antagonists and Thromboxane Synthase Inhibitors: New Targets to Treat Asthma

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 3, Iss. 1, 2004-03 ,pp. : 9-18

Bentham Science Publishers

Access to resources Recommend Favorite

Quantitative Structure - Activity Relationships (QSARs) of Thrombin Inhibitors: Review, Evaluation and Comparative Analysis

By  

Current Medicinal Chemistry, Vol. 10, Iss. 7, 2003-04 ,pp. : 525-577

Bentham Science Publishers

Access to resources Recommend Favorite

G 619, a dual thromboxane synthase inhibitor and thromboxane A 2 receptor antagonist, inhibits tumor necrosis factor- biosynthesis

By Altavilla D.   Squadrito F.   Canale P.   Ioculano M.   Squadrito G.   Campo G.M.   Serrano M.   Sardella A.   Urna G.   Spignoli G.   Caputi A.P.  

European Journal of Pharmacology, Vol. 286, Iss. 1, 1995-11 ,pp. : 31-39

Elsevier

Access to resources Recommend Favorite